CELG went into WITSEC last week due to the uncertainty surrounding its patent fight with Natco, the Markman hearing report came out today, I don't know much, well, anything about patent law, but ISI analyst Mark Schoenebaum, a very prudent and credible analyst in my opinion (helped me make a sht load of $ off GILD) said the result looked "OK", which is good enough...
I know a lot of you aren't fundamentalists, but I just wanna say that when the stars align (Fundamentals and Technicals), it indeed is a rare and fortunate occasion.
Nothing fundamental has changed, it just caught in a minor (bio/internet momo)correction last month, whcih I think is healthy. This bad boy got a little ahead of itself since Dec 2013, hammered back...
Many sector leaders like Gilead, Celgene, and Biogen all had a nice run up at the end of the week, which is encouraging given people tend to sell on Friday, especially in this market.
This bad boy went berserk in April 2013, flied away from this trend line and entered into a channel, which by the way, it broke exactly one year later, April 2014. Since then...
